{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T04:34:12Z","timestamp":1679632452354},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00108-022-01449-y","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T22:02:47Z","timestamp":1673388167000},"page":"340-350","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemische Amyloidoseformen mit kardialer Manifestation"],"prefix":"10.1007","volume":"64","author":[{"given":"Jan Philipp","family":"Huisl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester J.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"A\u00dfmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"1449_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","volume":"4","author":"G Merlini","year":"2018","unstructured":"Merlini\u00a0G, Dispenzieri\u00a0A, Sanchorawala\u00a0V et\u00a0al (2018) Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4:38. https:\/\/doi.org\/10.1038\/s41572-018-0034-3","journal-title":"Nat Rev Dis Primers"},{"key":"1449_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.26034","volume":"57","author":"HH Schmidt","year":"2018","unstructured":"Schmidt\u00a0HH, Waddington-Cruz\u00a0M, Botteman\u00a0MF et al (2018) Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve 57:829\u2013837. https:\/\/doi.org\/10.1002\/mus.26034","journal-title":"Muscle Nerve"},{"key":"1449_CR3","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","volume":"36","author":"E Gonz\u00e1lez-L\u00f3pez","year":"2015","unstructured":"Gonz\u00e1lez-L\u00f3pez\u00a0E, Gallego-Delgado\u00a0M, Guzzo-Merello\u00a0G et al (2015) Wild-type transthyretin amyloidosis as a\u00a0cause of heart failure with preserved ejection fraction. Eur Heart\u00a0J 36:2585\u20132594. https:\/\/doi.org\/10.1093\/eurheartj\/ehv338","journal-title":"Eur Heart J"},{"key":"1449_CR4","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1007\/s00108-018-0470-x","volume":"59","author":"A v. Kristen","year":"2018","unstructured":"v. Kristen\u00a0A (2018) What gnaws at the heart and gets on the nerves. Internist 59:1208\u20131213. https:\/\/doi.org\/10.1007\/s00108-018-0470-x","journal-title":"Internist"},{"key":"1449_CR5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","volume":"135","author":"MS Maurer","year":"2017","unstructured":"Maurer\u00a0MS, Elliott\u00a0P, Comenzo\u00a0R et\u00a0al (2017) Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 135:1357\u20131377. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024438","journal-title":"Circulation"},{"key":"1449_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s12181-019-00344-5","volume":"13","author":"A Yilmaz","year":"2019","unstructured":"Yilmaz\u00a0A, Bauersachs\u00a0J, Kindermann\u00a0I et\u00a0al (2019) Diagnostics and treatment of cardiac amyloidosis: position paper of the German Cardiac Society (DGK). Kardiologe 13:264\u2013291. https:\/\/doi.org\/10.1007\/s12181-019-00344-5","journal-title":"Kardiologe"},{"key":"1449_CR7","volume-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted county","author":"RA Kyle","year":"1950","unstructured":"Kyle\u00a0RA, Linos\u00a0A, Beard\u00a0CM et\u00a0al (1950) Incidence and natural history of primary systemic amyloidosis in Olmsted county"},{"key":"1449_CR8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011","volume-title":"High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement","author":"S Madan","year":"2012","unstructured":"Madan\u00a0S, Kumar\u00a0SK, Dispenzieri\u00a0A et al (2012) High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement https:\/\/doi.org\/10.1182\/blood-2011"},{"key":"1449_CR9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023144","volume-title":"Molecular mechanisms of amyloidosis","author":"G Merlini","year":"2003","unstructured":"Merlini\u00a0G, Bellotti\u00a0V (2003) Molecular mechanisms of amyloidosis"},{"key":"1449_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","volume":"20","author":"C Rapezzi","year":"2015","unstructured":"Rapezzi\u00a0C, Lorenzini\u00a0M, Longhi\u00a0S et\u00a0al (2015) Cardiac amyloidosis: the great pretender. Heart Fail Rev 20:117\u2013124. https:\/\/doi.org\/10.1007\/s10741-015-9480-0","journal-title":"Heart Fail Rev"},{"key":"1449_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000495455","volume":"141","author":"I Vaxman","year":"2019","unstructured":"Vaxman\u00a0I, Gertz\u00a0M (2019) Recent advances in the diagnosis, risk stratification, and management of systemic light-chain Amyloidosis. Acta Haematol 141:93\u2013106","journal-title":"Acta Haematol"},{"key":"1449_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/13506129.2011.571319","volume":"18","author":"SB Tsai","year":"2011","unstructured":"Tsai\u00a0SB, Seldin\u00a0DC, Wu\u00a0H et al (2011) Myocardial infarction with \u201cclean coronaries\u201d caused by amyloid light-chain AL amyloidosis: a\u00a0case report and literature review. Amyloid 18:160\u2013164. https:\/\/doi.org\/10.3109\/13506129.2011.571319","journal-title":"Amyloid"},{"key":"1449_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000489297","volume":"12","author":"M Hoscheit","year":"2018","unstructured":"Hoscheit\u00a0M, Kamal\u00a0A, Cline\u00a0M (2018) Gastroparesis in a\u00a0patient with gastric AL Amyloidosis. Case Rep Gastroenterol 12:317\u2013321. https:\/\/doi.org\/10.1159\/000489297","journal-title":"Case Rep Gastroenterol"},{"issue":"Suppl 4","key":"1449_CR14","first-page":"16427","volume":"99","author":"X Jiang","year":"2002","unstructured":"Jiang X, Hurshman AR, Powers ET et al (2002) Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc Natl Acad Sci 99(Suppl 4):16427\u201316432","journal-title":"Proc Natl Acad Sci"},{"key":"1449_CR15","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg\u00a0FL, Grogan\u00a0M, Hanna\u00a0M et al (2019) Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J\u00a0Am Coll Cardiol 73:2872\u20132891","journal-title":"J Am Coll Cardiol"},{"key":"1449_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/HCO.0000000000000547","volume":"33","author":"J Nativi-Nicolau","year":"2018","unstructured":"Nativi-Nicolau\u00a0J, Maurer\u00a0MS (2018) Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types. Curr Opin Cardiol 33:571\u2013579","journal-title":"Curr Opin Cardiol"},{"key":"1449_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.hjc.2019.10.004","volume":"61","author":"G Balciunaite","year":"2020","unstructured":"Balciunaite\u00a0G, Rimkus\u00a0A, Zurauskas\u00a0E et\u00a0al (2020) Transthyretin cardiac amyloidosis in aortic stenosis: prevalence, diagnostic challenges, and clinical implications. Hellenic J Cardiol 61:92\u201398","journal-title":"Hellenic J Cardiol"},{"key":"1449_CR18","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","volume":"74","author":"J Ternacle","year":"2019","unstructured":"Ternacle\u00a0J, Krapf\u00a0L, Mothy\u00a0D et\u00a0al (2019) Aortic stenosis and cardiac Amyloidosis: JACC review topic of the week. J\u00a0Am Coll Cardiol 74:2638\u20132651","journal-title":"J Am Coll Cardiol"},{"key":"1449_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","volume":"19","author":"JL Cavalcante","year":"2017","unstructured":"Cavalcante\u00a0JL, Rijal\u00a0S, Abdelkarim\u00a0I et\u00a0al (2017) Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. J\u00a0Cardiovasc Magn Reson 19:98. https:\/\/doi.org\/10.1186\/s12968-017-0415-x","journal-title":"J Cardiovasc Magn Reson"},{"key":"1449_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00428-001-0582-9","volume":"440","author":"C R\u00f6cken","year":"2002","unstructured":"R\u00f6cken\u00a0C, Shakespeare\u00a0A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111\u2013122","journal-title":"Virchows Arch"},{"key":"1449_CR21","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/ndt\/gfm684","volume":"23","author":"F Bergesio","year":"2008","unstructured":"Bergesio\u00a0F, Ciciani\u00a0AM, Manganaro\u00a0M et\u00a0al (2008) Renal involvement in systemic amyloidosis. Nephrol Dial Transplant 23:941\u2013951. https:\/\/doi.org\/10.1093\/ndt\/gfm684","journal-title":"Nephrol Dial Transplant"},{"key":"1449_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000508022","volume":"143","author":"B Wisniowski","year":"2020","unstructured":"Wisniowski\u00a0B, Wechalekar\u00a0A (2020) Confirming the diagnosis of amyloidosis. Acta Haematol 143:312\u2013321","journal-title":"Acta Haematol"},{"key":"1449_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/joim.13169","volume":"289","author":"E Muchtar","year":"2021","unstructured":"Muchtar\u00a0E, Dispenzieri\u00a0A, Magen\u00a0H et\u00a0al (2021) Systemic amyloidosis from A (AA) to T (ATTR): a\u00a0review. J\u00a0Intern Med 289:268\u2013292","journal-title":"J Intern Med"},{"key":"1449_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jama.2020.5493","volume":"324","author":"MA Gertz","year":"2020","unstructured":"Gertz\u00a0MA, Dispenzieri\u00a0A (2020) Systemic amyloidosis recognition, prognosis, and therapy: a systematic review. JAMA J Am Med Assoc 324:79\u201389","journal-title":"JAMA J Am Med Assoc"},{"key":"1449_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.2140","volume":"23","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia\u00a0P, Rapezzi\u00a0C, Adler\u00a0Y et al (2021) Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail 23:512\u2013526. https:\/\/doi.org\/10.1002\/ejhf.2140","journal-title":"Eur J Heart Fail"},{"key":"1449_CR26","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/ejhf.1756","volume":"22","author":"C Nitsche","year":"2020","unstructured":"Nitsche\u00a0C, Aschauer\u00a0S, Kammerlander\u00a0AA et al (2020) Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. Eur J Heart Fail 22:1852\u20131862. https:\/\/doi.org\/10.1002\/ejhf.1756","journal-title":"Eur J Heart Fail"},{"key":"1449_CR27","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","volume":"18","author":"DF Hutt","year":"2017","unstructured":"Hutt\u00a0DF, Fontana\u00a0M, Burniston\u00a0M et al (2017) Prognostic utility of the Perugini grading of 99m Tc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Eur Heart J Cardiovasc Imaging 18:1344\u20131350. https:\/\/doi.org\/10.1093\/ehjci\/jew325","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1449_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","volume":"28","author":"OK Siddiqi","year":"2018","unstructured":"Siddiqi\u00a0OK, Ruberg\u00a0FL (2018) Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med 28:10\u201321","journal-title":"Trends Cardiovasc Med"},{"key":"1449_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","volume":"6","author":"S Giancaterino","year":"2020","unstructured":"Giancaterino\u00a0S, Urey\u00a0MA, Darden\u00a0D et\u00a0al (2020) Management of arrhythmias in cardiac amyloidosis. JACC Clin Electrophysiol 6:351\u2013361","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"1449_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, Arbelo\u00a0E, Bax\u00a0JJ, Blomstr\u00f6m-Lundqvist\u00a0C, Boriani\u00a0G, Castella\u00a0M, Dan\u00a0G, Dilaveris\u00a0PE, Fauchier\u00a0L, Filippatos\u00a0G, Kalman\u00a0JM, Meir\u00a0ML, Lane\u00a0DA, Lebeau\u00a0J, Lettino\u00a0M, Lip\u00a0GYH, Pinto\u00a0FJ, Thomas\u00a0GN, Valgimigli\u00a0M, Gelder\u00a0ICV, Putte\u00a0BPV, Watkins\u00a0CL, ESC Scientific Document Group (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373\u2013498 https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"issue":"5","key":"1449_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41408-021-00486-4","volume":"11","author":"R al Hamed","year":"2021","unstructured":"al Hamed R, Bazarbachi AH, Bazarbachi A et\u00a0al (2021) Comprehensive review of AL amyloidosis: some practical recommendations. Blood Cancer\u00a0J 11(5):97. https:\/\/doi.org\/10.1038\/s41408-021-00486-4","journal-title":"Blood Cancer\u00a0J"},{"key":"1449_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12016-019-08759-4","volume":"59","author":"V D\u2019Aguanno","year":"2020","unstructured":"D\u2019Aguanno\u00a0V, Ralli\u00a0M, Artico\u00a0M et\u00a0al (2020) Systemic amyloidosis: a\u00a0contemporary overview. Clin Rev Allergy Immunol 59:304\u2013322","journal-title":"Clin Rev Allergy Immunol"},{"key":"1449_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/nejmoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer\u00a0MS, Schwartz\u00a0JH, Gundapaneni\u00a0B et\u00a0al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N\u00a0Engl J Med 379:1007\u20131016. https:\/\/doi.org\/10.1056\/nejmoa1805689","journal-title":"N Engl J Med"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01449-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T12:03:51Z","timestamp":1679573031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01449-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1449"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01449-y","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"28 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0A\u00dfmus hat Vortragshonorare von Pfizer erhalten. J.P.\u00a0Huisl und E.J.\u00a0Herrmann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}